top of page
SLLIP
SPANISH LUNG LIQUID VS. INVASIVE BIOPSY PROGRAM EVALUATION
CLINICAL TRIAL DETAILS
TUMOR DERIVED CELL FREE DNA (CFDNA) IS INCREASINGLY USED IN THE CLINIC TO OBTAIN GENOTYPE INFORMATION ABOUT LUNG CANCER, BUT ITS CONCORDANCE WITH CONCURRENT TUMOR-DERIVED SEQUENCED DATA IS NOT KNOWN. THE PRIMARY OBJECTIVE OF THIS STUDY IS TO DEMONSTRATE THE NON-INFERIORITY OF CFDNA-BASED VERSUS TUMOR TISSUE-BASED GENOTYPING.
COUNTRY
STATUS
TUMOR TYPE
PHASE
N
SITES
NSCLC
7
182
Observational
Spain
Closing
TRIAL OVERVIEW
PRESS RELEASE
-----
SCIENTIFIC IMPACT
BLOG ARTICLES RELATED
TRIAL SITES
Hospital Universitari Dexeus (Spain) | Hospital Universitari Vall D'Hebron (Spain) | Institut Català d' Oncologia L'Hospitalet (ICO) (Spain) | Hospital Santa Creu i Sant Pau (Spain) | Institut Català d' Oncologia Badalona (ICO) (Spain) | Hospital Arnau de Vilanova de Valencia (Spain) | Hospital del Mar (Spain)
Dr. Cortes and Dr. Llombart PHERain interview
Beyond Chemotherapy
Dr. Vanes Quiroga
Dr. Sofia Braga
Dr. Silvi Antolín
Dr. Escrivá de Romaní
Dr. Philipp Aftimos
Dr. Manuel Ruiz
Prof. Daniele Generali PHEGain interview
Dr. Jacques Medioni
Dr. Dunca Wheatley
TRIAL RESUME
bottom of page